Companies: 10,795·Total market cap: $144.5T
Oragenics, Inc.

Oragenics, Inc.

OGENAMEXHealthcare● Active
$0.61
+$0.02(+2.61%)
Market Cap$2750038
P/E Ratio
52W High$5.24
52W Low$0.5
Overview

Oragenics, Inc. (OGEN) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · OGEN · as of Jun 8, 2026

Activity summary

Buy transactions

0

P-Purchase only

Sell transactions

6

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

BEARISH
↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Oragenics, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

OGEN insider buying and selling by quarter

OGEN insider selling · OGEN insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
1.5M752K0
2024 Q3
2024 Q4
2025 Q2
2025 Q3

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · OGEN ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

OGEN executive sell shares · OGEN board member insider trading · OGEN insider trading SEC filing

Showing 33 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Telling Fred

Director

Sale

Date

Dec 12

Shares

210

Price

$0.94

Value

$198

View Form 4 on SEC.gov

KOSKI ROBERT C

Director

Other

Date

Dec 11

Shares

5,000

Price

$0.50

Value

$3K

View Form 4 on SEC.gov

DUNTON ALAN W

Director

Sale

Date

Dec 6

Shares

66

Price

$0.36

Value

$24

View Form 4 on SEC.gov

Telling Fred

Director

Sale

Date

Dec 6

Shares

3,597

Price

$0.36

Value

$1K

View Form 4 on SEC.gov

Telling Fred

Director

Sale

Date

Nov 30

Shares

3,500

Price

$3.57

Value

$12K

View Form 4 on SEC.gov

KOSKI ROBERT C

Director

Award

Date

Aug 8

Shares

25,000

Price

Value

View Form 4 on SEC.gov

POPE CHARLES L

Director

Award

Date

Aug 8

Shares

25,000

Price

Value

View Form 4 on SEC.gov

Murphy Kimberly M

CEO and President · Director

Award

Date

Aug 8

Shares

25,000

Price

Value

View Form 4 on SEC.gov

DUNTON ALAN W

Director

Award

Date

Aug 8

Shares

25,000

Price

Value

View Form 4 on SEC.gov

Huffman Janet

CFO, Secretary and Treasurer

Award

Date

Aug 8

Shares

15,000

Price

Value

View Form 4 on SEC.gov

Telling Fred

Director

Award

Date

Aug 8

Shares

25,000

Price

Value

View Form 4 on SEC.gov

KOSKI ROBERT C

Director

Sale

Date

Dec 30

Shares

42,357

Price

$0.11

Value

$4K

View Form 4 on SEC.gov

KOSKI ROBERT C

Director

Sale

Date

Dec 29

Shares

36,648

Price

$0.11

Value

$4K

View Form 4 on SEC.gov

KOSKI ROBERT C

Director

Sale

Date

Dec 14

Shares

25,000

Price

$0.17

Value

$4K

View Form 4 on SEC.gov

KOSKI ROBERT C

Director

Sale

Date

Dec 15

Shares

140,497

Price

$0.18

Value

$25K

View Form 4 on SEC.gov

KOSKI ROBERT C

Director

Sale

Date

Dec 14

Shares

4,503

Price

$0.17

Value

$788

View Form 4 on SEC.gov

KOSKI ROBERT C

Director

Sale

Date

Dec 9

Shares

48,795

Price

$0.20

Value

$10K

View Form 4 on SEC.gov

KOSKI ROBERT C

Director

Sale

Date

Dec 8

Shares

13,036

Price

$0.20

Value

$3K

View Form 4 on SEC.gov

KOSKI ROBERT C

Director

Sale

Date

Nov 29

Shares

200,000

Price

$0.19

Value

$38K

View Form 4 on SEC.gov

KOSKI ROBERT C

Director

Sale

Date

Nov 30

Shares

200,000

Price

$0.19

Value

$38K

View Form 4 on SEC.gov

Telling Fred

Director

Purchase

Date

Jun 17

Shares

10,084

Price

$0.29

Value

$3K

View Form 4 on SEC.gov

Telling Fred

Director

Purchase

Date

May 23

Shares

78,673

Price

$0.29

Value

$23K

View Form 4 on SEC.gov

Telling Fred

Director

Purchase

Date

May 23

Shares

3,500

Price

$0.29

Value

$1K

View Form 4 on SEC.gov

Telling Fred

Director

Purchase

Date

May 20

Shares

65,718

Price

$0.28

Value

$19K

View Form 4 on SEC.gov

Telling Fred

Director

Purchase

Date

May 19

Shares

56,806

Price

$0.28

Value

$16K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 2

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About OGEN insider trading

OGEN insider trades

Oragenics, Inc. (OGEN) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Telling Fred (Director). Over the past 12 months, 1 insiders have filed transactions with the SEC. OGEN insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Oragenics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

OGEN insider trading · 5 questions

The insiders of Oragenics, Inc. (OGEN) include executives and directors such as Telling Fred (Director), among others. Over the past 12 months, 1 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

OGEN board member insider tradingwho are OGEN insidersOGEN insider rosterOragenics, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026